-
[1]
Ling Su, Xia Zhou, Dan Yuan, Hong Yang, Dongbing Wei, Guangmin Qin, Shu Liang, 2014: Prevalence and patterns of drug-resistance mutations among HIV-1 patients infected with CRF07_BC strains in Sichuan province, China, Virologica Sinica, 29, 237-241. doi: 10.1007/s12250-014-3487-x
-
[2]
Jennifer Tisoncik-Go, Katie S Cordero, Lijun Rong, 2013: Analysis of Oseltamivir Resistance Substitutions in Influenza Virus Glycoprotein Neuraminidase using a Lentivirus-Based Surrogate Assay System, Virologica Sinica, 28, 81-91. doi: 10.1007/s12250-013-3307-8
-
[3]
Bei Wang, Chongyang Zhang, Xiaobo Lei, Lili Ren, He Huang, Jianwei Wang, Zhendong Zhao, 2021: Construction of Non-infectious SARS-CoV-2 Replicons and Their Application in Drug Evaluation, Virologica Sinica, 36, 890-900. doi: 10.1007/s12250-021-00369-9
-
[4]
Inderdeep Kaur, C Gupta R, Puri Munish, 2011: Ribosome Inactivating Proteins from Plants Inhibiting Viruses *, Virologica Sinica, 26, 357-365. doi: 10.1007/s12250-011-3223-8
-
[5]
王学, 周莹, 田波, 1999: Receptors and coreceptors of human immunodeficiency virus, Virologica Sinica, 14, 7-10.
-
[6]
Dan Luo, Qing Ye, Rui-Ting Li, Hang-Yu Zhou, Jing-Jing Guo, Suo-Qun Zhao, Sen Zhang, Tao Jiang, Yong-Qiang Deng, Cheng-Feng Qin, 2023: PA-E18G substitution in influenza A virus confers resistance to ZX-7101, a cap-dependent endonuclease inhibitor, Virologica Sinica, 38, 559-567. doi: 10.1016/j.virs.2023.06.002
-
[7]
Xin-ping LI, Hui XING, Zhe WANG, Xue-feng SI, Lian-en WANG, Hua CHENG, Wei-guo CUI, Shu-lin JIANG, Ling-jie LIAO, Hai-wei ZHOU, Jiang-hong HUANG, Hong PENG, Peng-fei MA, Yi-ming SHAO, 2007: Study of HIV-1 Drug Resistance in Patients Receiving Free Antiretroviral Therapy in China, Virologica Sinica, 22, 233-240.
-
[8]
Tingting Li, Feng Qian, Ting Yuan, Weilu Xu, Li Zhu, Jinlong Huang, Haiyan Wang, Yueping Zhu, Yinling Wang, Xiaohong Li, Saihong Gu, Zhuqing Tan, Hui Chen, Xiangrong Luo, Wei Zhu, Wenjuan Lu, Ping Xu, Ming Li, Yuying Chen, Yong Gao, Rongge Yang, Chuanwu Zhu, Binlian Sun, 2017: Drug resistance mutation profiles of the drug-naïve and first-line regimen-treated HIV-1-infected population of Suzhou, China, Virologica Sinica, 32, 271-279. doi: 10.1007/s12250-017-4002-y
-
[9]
Susan L. Uprichard, 2010: Hepatitis C Virus Experimental Model Systems and Antiviral drug Research*, Virologica Sinica, 25, 227-245. doi: 10.1007/s12250-010-3134-0
-
[10]
许铭炎, 马军, 洪坤学, 邓小玲, 刘永超, 阮玉华, 邢辉, 张远志, 徐小虎, 邵一鸣, 2005: HLA-B Alleles Associated with Susceptibility or Resistance to Human Immunodeficiency Virus Type 1 in a Xinjiang Uygur Population, China, Virologica Sinica, 20, 594-599.
-
[11]
Qing-mao GENG, Han-ping LI, Zuo-yi BAO, Yong-jian LIU, Dao-min ZHUANG, Lin LI, Si-yang LIU, Jing-yun LI, 2010: Indinavir Resistance Evolution in One Human Immunodeficiency Virus Type 1 Infected Patient Revealed by Single-Genome Amplification*, Virologica Sinica, 25, 316-328. doi: 10.1007/s12250-010-3122-4
-
[12]
Matthew Brecher, Jing Zhang, Hongmin Li, 2013: The Flavivirus Protease As a Target for Drug Discovery, Virologica Sinica, 28, 326-336. doi: 10.1007/s12250-013-3390-x
-
[13]
刘强, 杨贵波, 邵一鸣*, 2006: SHIV Construction and Application in the AIDS Vaccine and Drug Research, Virologica Sinica, 21, 523-527.
-
[14]
Ren-rong TIAN, Qing-jiao LIAO, Xu-lin CHEN, 2007: Current Status of Targets and Assays for Anti-HIV Drug Screening, Virologica Sinica, 22, 476-485.
-
[15]
张春涛, 李秀华, 宋爱京, 许四宏, 王佑春*, 2005: The Relationship of the Nucleic Acid and Antibody of HIV/HCV Among Drug Users, Virologica Sinica, 20, 600-602.
-
[16]
Chunchen Wu, Baolin Li, Xiaoyong Zhang, Kaitao Zhao, Yingshan Chen, Yifei Yuan, Yan Liu, Rongjuan Chen, Dongping Xu, Xinwen Chen, Mengji Lu, 2019: Complementation of Wild-Type and Drug-Resistant Hepatitis B Virus Genomes to Maintain Viral Replication and Rescue Virion Production under Nucleos(t)ide Analogs, Virologica Sinica, 34, 377-385. doi: 10.1007/s12250-019-00143-y
-
[17]
Jian Gong, Xiao-qiong Wang, Xiao Tong, Xi-hui Shen, Rong-ge Yang, 2011: Emerging Trends of Drug-Resistant HIV-1 among Drug-Treated Patients in Former Blood Donors in Hubei, China: a Three-Year Surveillance from 2004 to 2006, Virologica Sinica, 26, 386-392. doi: 10.1007/s12250-011-3210-0
-
[18]
Deyin Guo, 2020: Old Weapon for New Enemy: Drug Repurposing for Treatment of Newly Emerging Viral Diseases, Virologica Sinica, 35, 253-255. doi: 10.1007/s12250-020-00204-7
-
[19]
Yun-Yun Jin, Hanwen Lin, Liu Cao, Wei-Chen Wu, Yanxi Ji, Liubing Du, Yiling Jiang, Yanchun Xie, Kuijie Tong, Fan Xing, Fuxiang Zheng, Mang Shi, Ji-An Pan, Xiaoxue Peng, Deyin Guo, 2021: A Convenient and Biosafe Replicon with Accessory Genes of SARS-CoV-2 and Its Potential Application in Antiviral Drug Discovery, Virologica Sinica, 36, 913-923. doi: 10.1007/s12250-021-00385-9
-
[20]
Qiwen Fang, Zhenqiu Liu, Zhijie Zhang, Yan Zeng, Tiejun Zhang, 2017: Prevalence of Kaposi’s sarcoma-associated herpesvirus among intravenous drug users: a systematic review and meta-analysis, Virologica Sinica, 32, 415-422. doi: 10.1007/s12250-017-4051-2